A citation-based method for searching scientific literature

Julien Kirchgesner, Magali Lemaitre, Fabrice Carrat, Mahmoud Zureik, Franck Carbonnel, Rosemary Dray-Spira. Gastroenterology 2018
Times Cited: 248







List of co-cited articles
798 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
Erica J Brenner, Ryan C Ungaro, Richard B Gearry, Gilaad G Kaplan, Michele Kissous-Hunt, James D Lewis, Siew C Ng, Jean-Francois Rahier, Walter Reinisch, Frank M Ruemmele,[...]. Gastroenterology 2020
406
25

Infliximab, azathioprine, or combination therapy for Crohn's disease.
Jean Frédéric Colombel, William J Sandborn, Walter Reinisch, Gerassimos J Mantzaris, Asher Kornbluth, Daniel Rachmilewitz, Simon Lichtiger, Geert D'Haens, Robert H Diamond, Delma L Broussard,[...]. N Engl J Med 2010
21

Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, Bruce A Salzberg, Robert H Diamond, Samiyeh Price, Wayne Langholff, Anil Londhe, William J Sandborn. Am J Gastroenterol 2012
496
20

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
Magali Lemaitre, Julien Kirchgesner, Annie Rudnichi, Fabrice Carrat, Mahmoud Zureik, Franck Carbonnel, Rosemary Dray-Spira. JAMA 2017
260
19

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
J F Rahier, F Magro, C Abreu, A Armuzzi, S Ben-Horin, Y Chowers, M Cottone, L de Ridder, G Doherty, R Ehehalt,[...]. J Crohns Colitis 2014
602
16

The safety of vedolizumab for ulcerative colitis and Crohn's disease.
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, William Sandborn, Silvio Danese, Geert D'Haens, Remo Panaccione, Edward V Loftus, Serap Sankoh, Irving Fox,[...]. Gut 2017
426
15

Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Brian G Feagan, Paul Rutgeerts, Bruce E Sands, Stephen Hanauer, Jean-Frédéric Colombel, William J Sandborn, Gert Van Assche, Jeffrey Axler, Hyo-Jong Kim, Silvio Danese,[...]. N Engl J Med 2013
15

Vedolizumab as induction and maintenance therapy for Crohn's disease.
William J Sandborn, Brian G Feagan, Paul Rutgeerts, Stephen Hanauer, Jean-Frédéric Colombel, Bruce E Sands, Milan Lukas, Richard N Fedorak, Scott Lee, Brian Bressler,[...]. N Engl J Med 2013
14

Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
Siddharth Singh, Antonio Facciorusso, Parambir S Dulai, Vipul Jairath, William J Sandborn. Clin Gastroenterol Hepatol 2020
82
15

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study.
Cristina Bezzio, Simone Saibeni, Angela Variola, Mariangela Allocca, Alessandro Massari, Viviana Gerardi, Valentina Casini, Chiara Ricci, Fabiana Zingone, Arnaldo Amato,[...]. Gut 2020
202
13

Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Ryan C Ungaro, Erica J Brenner, Richard B Gearry, Gilaad G Kaplan, Michele Kissous-Hunt, James D Lewis, Siew C Ng, Jean-Francois Rahier, Walter Reinisch, Flávio Steinwurz,[...]. Gut 2021
151
13

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
William J Sandborn, Chinyu Su, Bruce E Sands, Geert R D'Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G Feagan, Walter Reinisch, Wojciech Niezychowski,[...]. N Engl J Med 2017
660
12

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager,[...]. J Crohns Colitis 2020
297
12

Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
Remo Panaccione, Subrata Ghosh, Stephen Middleton, Juan R Márquez, Boyd B Scott, Laurence Flint, Hubert J F van Hoogstraten, Annie C Chen, Hanzhe Zheng, Silvio Danese,[...]. Gastroenterology 2014
561
12

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Brian G Feagan, William J Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R Friedman, Marion A Blank, Jewel Johanns, Long-Long Gao, Ye Miao,[...]. N Engl J Med 2016
821
11

Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
Andrew Tinsley, Seyedehsan Navabi, Emmanuelle D Williams, Guodong Liu, Lan Kong, Matthew D Coates, Kofi Clarke. Inflamm Bowel Dis 2019
75
14

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Nicholas A Kennedy, Graham A Heap, Harry D Green, Benjamin Hamilton, Claire Bewshea, Gareth J Walker, Amanda Thomas, Rachel Nice, Mandy H Perry, Sonia Bouri,[...]. Lancet Gastroenterol Hepatol 2019
235
11

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan,[...]. Lancet 2017
11

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu'Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger,[...]. Gut 2019
545
11

British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, Richard Appleby, Ian Arnott, R Mark Beattie, Stuart Bloom, Alenka J Brooks, Rachel Cooney, Robin J Dart,[...]. Gut 2020
158
11

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Bruce E Sands, Laurent Peyrin-Biroulet, Edward V Loftus, Silvio Danese, Jean-Frédéric Colombel, Murat Törüner, Laimas Jonaitis, Brihad Abhyankar, Jingjing Chen, Raquel Rogers,[...]. N Engl J Med 2019
231
11

AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
David T Rubin, Joseph D Feuerstein, Andrew Y Wang, Russell D Cohen. Gastroenterology 2020
146
10

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
Dana J Lukin, Anand Kumar, Kaveh Hajifathalian, Reem Z Sharaiha, Ellen J Scherl, Randy S Longman. Gastroenterology 2020
75
13

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn's Disease: A Prospective, Randomized Trial.
Takayuki Matsumoto, Satoshi Motoya, Kenji Watanabe, Tadakazu Hisamatsu, Hiroshi Nakase, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki,[...]. J Crohns Colitis 2016
125
9

2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases.
Carlos Taxonera, Iñigo Sagastagoitia, Cristina Alba, Norberto Mañas, David Olivares, Enrique Rey. Aliment Pharmacol Ther 2020
114
9

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.
Stefanos Bonovas, Gionata Fiorino, Mariangela Allocca, Theodore Lytras, Georgios K Nikolopoulos, Laurent Peyrin-Biroulet, Silvio Danese. Clin Gastroenterol Hepatol 2016
203
9

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management.
Fernando Gomollón, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James O Lindsay, Laurent Peyrin-Biroulet, Garret J Cullen, Marco Daperno, Torsten Kucharzik,[...]. J Crohns Colitis 2017
9

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.
Laurent Beaugerie, Nicole Brousse, Anne Marie Bouvier, Jean Frédéric Colombel, Marc Lémann, Jacques Cosnes, Xavier Hébuterne, Antoine Cortot, Yoram Bouhnik, Jean Pierre Gendre,[...]. Lancet 2009
738
9

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
Marcus Harbord, Rami Eliakim, Dominik Bettenworth, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Torsten Kucharzik, Tamás Molnár, Tim Raine, Shaji Sebastian,[...]. J Crohns Colitis 2017
579
9

ACG Clinical Guideline: Management of Crohn's Disease in Adults.
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. Am J Gastroenterol 2018
483
8

ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
Francis A Farraye, Gil Y Melmed, Gary R Lichtenstein, Sunanda V Kane. Am J Gastroenterol 2017
247
8

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.
Kevin L Winthrop, Gil Y Melmed, Séverine Vermeire, Millie D Long, Gary Chan, Ronald D Pedersen, Nervin Lawendy, Andrew J Thorpe, Chudy I Nduaka, Chinyu Su. Inflamm Bowel Dis 2018
110
8

Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease.
Brian G Feagan, John W D McDonald, Remo Panaccione, Robert A Enns, Charles N Bernstein, Terry P Ponich, Raymond Bourdages, Donald G Macintosh, Chrystian Dallaire, Albert Cohen,[...]. Gastroenterology 2014
217
8

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis.
Bruce E Sands, William J Sandborn, Remo Panaccione, Christopher D O'Brien, Hongyan Zhang, Jewel Johanns, Omoniyi J Adedokun, Katherine Li, Laurent Peyrin-Biroulet, Gert Van Assche,[...]. N Engl J Med 2019
342
8

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L Peyrin-Biroulet, W Sandborn, B E Sands, W Reinisch, W Bemelman, R V Bryant, G D'Haens, I Dotan, M Dubinsky, B Feagan,[...]. Am J Gastroenterol 2015
8

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Stephen B Hanauer, Brian G Feagan, Gary R Lichtenstein, Lloyd F Mayer, S Schreiber, Jean Frederic Colombel, Daniel Rachmilewitz, Douglas C Wolf, Allan Olson, Weihang Bao,[...]. Lancet 2002
8

COVID-19 and immunomodulation in IBD.
Markus F Neurath. Gut 2020
143
8

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.
Xavier Roblin, Nicolas Williet, Gilles Boschetti, Jean-Marc Phelip, Emilie Del Tedesco, Anne-Emmanuelle Berger, Philippe Vedrines, Gerard Duru, Laurent Peyrin-Biroulet, Stéphane Nancey,[...]. Gut 2020
50
16

Increased risk of pneumonia among patients with inflammatory bowel disease.
Millie D Long, Christopher Martin, Robert S Sandler, Michael D Kappelman. Am J Gastroenterol 2013
125
7

Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
Nabeel Khan, Dhruvan Patel, Chinmay Trivedi, Yash Shah, Gary Lichtenstein, James Lewis, Yu-Xiao Yang. Clin Gastroenterol Hepatol 2018
61
11

Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B Hanauer, Gary R Lichtenstein,[...]. N Engl J Med 2005
7

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
William J Sandborn, Julián Panés, Geert R D'Haens, Bruce E Sands, Chinyu Su, Michele Moscariello, Thomas Jones, Ron Pedersen, Gary S Friedman, Nervin Lawendy,[...]. Clin Gastroenterol Hepatol 2019
114
7

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
X Roblin, G Boschetti, N Williet, S Nancey, H Marotte, A Berger, J M Phelip, L Peyrin-Biroulet, J F Colombel, E Del Tedesco,[...]. Aliment Pharmacol Ther 2017
79
8

Risk factors for opportunistic infections in patients with inflammatory bowel disease.
Murat Toruner, Edward V Loftus, W Scott Harmsen, Alan R Zinsmeister, Robert Orenstein, William J Sandborn, Jean-Frederic Colombel, Laurence J Egan. Gastroenterology 2008
727
7

ACG Clinical Guideline: Ulcerative Colitis in Adults.
David T Rubin, Ashwin N Ananthakrishnan, Corey A Siegel, Bryan G Sauer, Millie D Long. Am J Gastroenterol 2019
435
7

Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Laurent Beaugerie, Jean-François Rahier, Julien Kirchgesner. Clin Gastroenterol Hepatol 2020
30
23

Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts.
Mariangela Allocca, Gionata Fiorino, Camille Zallot, Federica Furfaro, Daniela Gilardi, Simona Radice, Silvio Danese, Laurent Peyrin-Biroulet. Clin Gastroenterol Hepatol 2020
78
8

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's Disease.
Aleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, Graham A Heap, Daniel L Rice, Mark Reppell, Claire M Bewshea, Neil Chanchlani, Gareth J Walker, Mandy H Perry,[...]. Gastroenterology 2020
122
7


Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease.
Gil Y Melmed, Nik Agarwal, Robert W Frenck, Andrew F Ippoliti, Patricio Ibanez, Konstantinos A Papadakis, Peter Simpson, Cristina Barolet-Garcia, Joel Ward, Stephan R Targan,[...]. Am J Gastroenterol 2010
136
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.